Clinical trials
Phase 3 Recurrence trials in Romania
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 3 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 2 |
| 2015 | 1 |
| 2017 | 2 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Recruiting | 4 |
| Active, not recruiting | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biogen | 5 |
| Bristol-Myers Squibb | 2 |
| Celgene | 2 |
| Novartis Pharmaceuticals | 2 |
| AVEO Pharmaceuticals, Inc. | 1 |
| Amgen | 1 |
| AstraZeneca | 1 |
| CTI BioPharma | 1 |
| Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 1 |
| Janssen-Cilag International NV | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 21 |
| Multiple Myeloma | 6 |
| Multiple Sclerosis | 6 |
| Multiple Sclerosis, Relapsing-Remitting | 3 |
| Bone Marrow Neoplasms | 1 |
| Carcinoma, Renal Cell | 1 |
| Carcinoma, Squamous Cell | 1 |
| Disease | 1 |
| Head and Neck Neoplasms | 1 |
| Kidney Neoplasms | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.